IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 101 a 120 di 247
Titolo Data di pubblicazione Autore(i) File
Enoxaparin, aspirin, or warfarin for thromboprophilaxis in newly diagnosed myeloma patients receiving thalidomide: a randomized controlled trial 1-gen-2010 Magarotto, V; Brioli, A; Patriarca, F; Rossi, D; Petrucci, M. T.; Nozzoli, C; Ria, Roberto; Torelli, G; Baldini, L; Callea, V; Ledda, A; Rizzo, M; Ferrara, F; Califano, C; Fattori, P; Rizzi, Rita; Varaldi, A; Ravaioli, A; Guardigni, L; Morabito, F; Offidani, M; Zamagni, E; Bringhen, S; Tosi, P; Boccadoro, M; Palumbo, A; Cavo, M.
The bone marrow microenvironment in multiple mieloma: cellular and molecular basis of disease progression 1-gen-2010 Ria, Roberto; Reale, A; Mangialardi, G; Dammacco, F; Ribatti, Domenico; Vacca, Angelo
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial 1-gen-2010 Palumbo, A; Bringhen, S; Rossi, D; Cavalli, M; Larocca, A; Ria, Roberto; Offidani, M; Patriarca, F; Nozzoli, C; Guglielmelli, T; Benevolo, G; Callea, V; Baldini, L; Morabito, F; Grasso, M; Leonardi, G; Rizzo, M; PIA FALCONE, A; Gottardi, D; Montefusco, V; Musto, P; Petrucci, Mt; Ciccone, G; Boccadoro, M.
Role of angiogenesis and microenvironment in melanoma progression 1-gen-2011 Ria, Roberto; Reale, A; Vacca, Angelo
ELEVATED VEGF-PLASMA LEVELS IN ESSENTIAL HYPERTENSION 1-gen-2011 Ria, Roberto; Ficarazzo, G; Stefanutti, G; Ranieri, Giuseppe
90y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell trasplantation in aggressive non-Hodgkin lymphoma 1-gen-2011 Ria, Roberto; Musto, P; Reale, A; Guariglia, R; Iodice, G; Dammacco, F; Vacca, Angelo
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial 1-gen-2011 Palumbo, A; Cavo, M; Bringhen, S; Zamagni, E; Romano, A; Patriarca, F; Rossi, D; Gentilini, F; Crippa, C; Galli, M; Nozzoli, C; Ria, Roberto; Marasca, R; Montefusco, V; Baldini, L; Elice, F; Callea, V; Pulini, S; Carella, Am; Zambello, R; Benevolo, G; Magarotto, V; Tacchetti, P; Pescosta, N; Cellini, C; Polloni, C; Evangelista, A; Caravita, T; Morabito, F; Offidani, M; Tosi, P; Boccadoro, M.
Bone marrow angiogenesis and progression in multiple myeloma 1-gen-2011 Ria, Roberto; Reale, A.; DE LUISI, A.; Ferrucci, A.; Moschetta, M.; Vacca, Angelo
The bone marrow microenvironment in multiple myeloma: Cellular and molecular basis of disease progression 1-gen-2011 Ria, R.; Reale, A.; Mangialardi, G.; Dammacco, D.; Ribatti, D.; Vacca, A.
Lenalidomide restrains motility and overangiogenic potential of bone marrow endothelial cells in patients with active multiple myeloma 1-gen-2011 DE LUISI, A; Ferrucci, A; Coluccia, Am; Ria, Roberto; Moschetta, M; DE LUCA, E; Pieroni, L; Maffia, M; Urbani, A; DI PIETRO, G; Guarini, A; Ranieri, G; Ditonno, P; Berardi, S; Caivano, A; Basile, A; Cascavilla, N; Capalbo, S; Quarta, G; Dammacco, F; Ribatti, Domenico; Vacca, Angelo
90Y-ibritumomab tiuxetan as consolidation therapy after autologous stem cell transplantation in aggressive non-Hodgkin lymphoma 1-gen-2011 Ria, R; Musto, P; Reale, A; Guariglia, R; Iodice, G; Dammacco, F; Vacca, A
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone(VMP) in untreated multiple myeloma patients with renal impairment. 1-gen-2011 Morabito, F; Gentile, M; Mazzone, C; Rossi, D; DI RAIMONDO, F; Bringhen, S; Ria, Roberto; Offidani, M; Patriarca, F; Nozzoli, C; Petrucci, Mt; Benevolo, G; Vincelli, I; Guglielmelli, T; Grasso, M; Marasca, R; Baldini, L; Montefusco, V; Musto, P; Cascavilla, N; Majolino, I; Musolino, C; Cavo, M; Boccadoro, M; Palumbo, A.
The relationship between vascular endothelial growth factor and microalbuminuria in patients with essential hypertension 1-gen-2011 Ria, Roberto; Ficarazzo, G; Stefanutti, G; Ranieri, Giuseppe
Increased serum concentrations of soluble adhesion molecules in "non-dippers" hypertensives. 1-gen-2012 Ria, R; DI TERLIZZI, M; Cavallo, Ml; Ranieri, Giuseppe
Vascular endothelial growth factor and its receprtors in multiple myeloma 1-gen-2012 Ria, R.; Reale, A; Vacca, A
Vascular Endothelial Growth Factor and its Receptors in Multiple Myeloma 1-gen-2012 Ria, Roberto; Reale, A; Vacca, Angelo
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: Clinical results and effects on microenvironment and neo-angiogenic biomarkers 1-gen-2012 Zaja, Francesco; De Luca, Stefano; Vitolo, Umberto; Orsucci, Lorella; Levis, Alessandro; Salvi, Flavia; Rusconi, Chiara; Ravelli, Erika; Tucci, Alessandra; Bottelli, Chiara; Balzarotti, Monica; Brusamolino, Ercole; Bonfichi, Maurizio; Pileri, Stefano A.; Sabattini, Elena; Volpetti, Stefano; Monagheddu, Chiara; Vacca, Angelo; Ria, Roberto; Fanin, Renato
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma 1-gen-2012 Falzetti, Franca; Ianni, Mauro Di; Ballanti, Stelvio; Iodice, Giuseppe; Reale, Antonia; Minelli, Olivia; Serio, Gabriella; Martelli, Massimo F.; Dammacco, Franco; Vacca, Angelo; Ria, Roberto
Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma 1-gen-2012 Ria, R.; Reale, A.; Solimando, A. G.; Mangialardi, G.; Moschetta, M.; Gelao, L.; Iodice, G.; Vacca, A.
Could multiple myeloma VEGF modify the systemic microcirculation? 1-gen-2012 Cicco, S.; DI TONNO, P.; Reale, A.; Savino, S.; Castrovilli, A.; Catacchio, I.; Ria, Roberto; Vacca, Angelo
Mostrati risultati da 101 a 120 di 247
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile